![PDF) Effect of withdrawal of fusafungine from the market on prescribing of antibiotics and other alternative treatments in Germany: a pharmacovigilance impact study PDF) Effect of withdrawal of fusafungine from the market on prescribing of antibiotics and other alternative treatments in Germany: a pharmacovigilance impact study](https://i1.rgstatic.net/publication/331549572_Effect_of_withdrawal_of_fusafungine_from_the_market_on_prescribing_of_antibiotics_and_other_alternative_treatments_in_Germany_a_pharmacovigilance_impact_study/links/5c9377c7299bf111693bf990/largepreview.png)
PDF) Effect of withdrawal of fusafungine from the market on prescribing of antibiotics and other alternative treatments in Germany: a pharmacovigilance impact study
![Fusafungine-containing medicines should be withdrawn, says European Medicines Agency - The Pharmaceutical Journal Fusafungine-containing medicines should be withdrawn, says European Medicines Agency - The Pharmaceutical Journal](https://pharmaceutical-journal.com/wp-content/uploads/2021/01/young-man-using-nasal-spray-16-scaled.jpg)
Fusafungine-containing medicines should be withdrawn, says European Medicines Agency - The Pharmaceutical Journal
![Dominique Dupagne on X: "@Fraslin SERVIER intriguerait pour faire réévaluer dans la COVID19 l'inénarrable LOCABIOTAL PRESSURISE des années 70. Un pschitt dans la gorge, un dans le nez et un dans les Dominique Dupagne on X: "@Fraslin SERVIER intriguerait pour faire réévaluer dans la COVID19 l'inénarrable LOCABIOTAL PRESSURISE des années 70. Un pschitt dans la gorge, un dans le nez et un dans les](https://pbs.twimg.com/media/EkODa-yXcAABuT0.jpg)
Dominique Dupagne on X: "@Fraslin SERVIER intriguerait pour faire réévaluer dans la COVID19 l'inénarrable LOCABIOTAL PRESSURISE des années 70. Un pschitt dans la gorge, un dans le nez et un dans les
![Bioparox Spray - Uses, DMF, Dossier, Manufacturer, Supplier, Licensing, Distributer, Prices, News, GMP Bioparox Spray - Uses, DMF, Dossier, Manufacturer, Supplier, Licensing, Distributer, Prices, News, GMP](https://www.pharmacompass.com/image/ads250/renejix-m-14627.gif)